IGF-I synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle

Dev Biol. 2001 Apr 15;232(2):414-23. doi: 10.1006/dbio.2001.0208.

Abstract

Secreted peptide growth factors are critical extracellular signals that interact to promote the proliferation, differentiation, and survival of progenitor cells in developing tissues. IGF-I signaling through the IGF type I receptor provides a mitogenic signal for numerous cell types, including stem and progenitor cells. We have utilized the O-2A oligodendrocyte progenitor to study the mechanism of IGF-I mitogenic actions since these progenitors respond to IGF-I in vitro, and gene targeting studies in mice have demonstrated that IGF-I is essential for normal oligodendrocyte development in vivo. The goal of this study was to elucidate the mechanism by which IGF-I promotes the proliferation of oligodendrocyte progenitors in the context of other mitogens critical for their proliferation. Results presented here show that IGF-I significantly amplified the actions of FGF-2 and PDGF to promote DNA synthesis in O-2A progenitors. Investigation of cell cycle kinetics revealed that IGF-I had no significant effect on the rate of cell cycle progression. Instead, IGF-I promoted increased recruitment of O-2A progenitors into the S phase of the cell cycle. These studies support a role for IGF-I as a cell cycle progression factor for progenitor cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bromodeoxyuridine / metabolism
  • Cell Cycle / drug effects
  • Cells, Cultured
  • DNA / biosynthesis
  • Drug Synergism
  • Fibroblast Growth Factor 2 / administration & dosage*
  • Insulin-Like Growth Factor I / administration & dosage*
  • Kinetics
  • Oligodendroglia / cytology*
  • Oligodendroglia / drug effects*
  • Oligodendroglia / metabolism
  • Platelet-Derived Growth Factor / administration & dosage
  • Rats
  • S Phase / drug effects
  • Stem Cells / cytology
  • Stem Cells / drug effects
  • Stem Cells / metabolism

Substances

  • Platelet-Derived Growth Factor
  • Fibroblast Growth Factor 2
  • Insulin-Like Growth Factor I
  • DNA
  • Bromodeoxyuridine